Maze Therapeutics IPO

Maze Therapeutics is a biotechnology company focused on developing novel therapeutics to treat genetic diseases. The company's mission is to address the underlying genetic causes of disease and enable the development of targeted therapies that can improve patients' lives.

Register for Details

For more details on financing and valuation for Maze Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Maze Therapeutics

Forge green plus iconForge green minus icon

What is Maze Therapeutics's IPO price?

The IPO price for Maze Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Maze Therapeutics?

Maze Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Maze Therapeutics shares pre-IPO?

If you own Maze Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Maze Therapeutics a publicly traded company?

Maze Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Maze Therapeutics's funding to date?

Maze Therapeutics has raised $383.9MM to date.
Forge green plus iconForge green minus icon

When was Maze Therapeutics founded?

Maze Therapeutics was founded in 2018.

Maze Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
1/10/2022 Series C $120.62MM raised $XXX.XX $XXX.XX
10/25/2019 Series B $158.3MM raised $XXX.XX $XXX.XX
2/28/2019 Series A $104.99MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.